Sudeep Pharma Intrinsic Value
Sudeep Pharma (SUDEEPPHRM) median intrinsic value is ₹554.65 from 9 valuation models (range ₹195–₹1300), vs current price ₹650.10 — -14.7% downside (Trading Above Median Value), margin of safety -17.2%. Also explore Sudeep Pharma stock price data download to track price trends across different timeframes.
SUDEEPPHRM Valuation Methods Summary — DCF, Graham Number & P/E
Sudeep Pharma intrinsic value across 9 models vs current price ₹650.10 — upside/downside and value range per method. For current market price and key ratios, visit Sudeep Pharma stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹369.60 | ₹295.68 - ₹443.52 | -43.1% | EPS: ₹16.80, Sector P/E: 22x |
| Book Value Method | asset | ₹821.67 | ₹739.50 - ₹903.84 | +26.4% | Book Value/Share: ₹410.83, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1153.33 | ₹1038.00 - ₹1268.66 | +77.4% | Revenue/Share: ₹576.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1300.20 | ₹1170.18 - ₹1430.22 | +100.0% | EBITDA: ₹264.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹554.65 | ₹443.72 - ₹665.58 | -14.7% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹195.03 | ₹175.53 - ₹214.53 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹259.56 | ₹233.60 - ₹285.52 | -60.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1300.20 | ₹1170.18 - ₹1430.22 | +100.0% | ROE: 38.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹394.07 | ₹354.66 - ₹433.48 | -39.4% | EPS: ₹16.80, BVPS: ₹410.83 |
SUDEEPPHRM Intrinsic Value vs Market Price — All Valuation Models
Sudeep Pharma fair value range ₹195–₹1300 vs current market price ₹650.10 across 9 valuation models. Browse SUDEEPPHRM balance sheet details for revenue, profit, balance sheet and cash flow data.
SUDEEPPHRM Intrinsic Value Analysis — Undervalued or Overvalued?
Sudeep Pharma median intrinsic value ₹554.65, current price ₹650.10 — Trading Above Median Value by 14.7%, margin of safety -17.2%.
What is the intrinsic value of SUDEEPPHRM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sudeep Pharma (SUDEEPPHRM) is ₹554.65 (median value). With the current market price of ₹650.10, this represents a -14.7% variance from our estimated fair value.
The valuation range spans from ₹195.03 to ₹1300.20, indicating ₹195.03 - ₹1300.20.
Is SUDEEPPHRM undervalued or overvalued?
Based on our multi-method analysis, Sudeep Pharma (SUDEEPPHRM) appears to be trading above median value by approximately 14.7%.
SUDEEPPHRM Financial Health — Key Ratios vs Industry Benchmarks
Sudeep Pharma financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.65 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 38.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 34.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.97x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SUDEEPPHRM Cash Flow Quality — Operating & Free Cash Flow
Sudeep Pharma operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹49 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹66 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-3 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹35 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2020 | ₹10 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |